In a separate study, METTL3 promotes activation of the glycolytic pathway in CRC patients by interacting directly with the 5′/3′UTR region of HK2 and the 3′UTR region of GLUT1. The gene discussed is SLC2A1; the disease is colorectal carcinoma.